{"@context":{"@vocab":"https://schema.org/"},"@type":"Legislation","@id":"https://api.ai-analytics.org/trade-case/8728#inv","name":"Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Inv. No. 337-TA-1447 (Violation)","legislationIdentifier":"337-1447","datePublished":"2025-05-02","description":"USITC Section 337 (unfair imports / IP) investigation 337-1447 — Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof. Active.","url":"https://ids.usitc.gov/case/8276/investigation/8728","isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","investigation":{"investigation_id":8728,"investigation_number":"337-1447","case_class":"SECTION_337","type":"Unfair Imports","title":"Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Inv. No. 337-TA-1447 (Violation)","product":"Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof","phase":"Violation 1","start_date":"2025-05-02","end_date":null,"active":true,"ids_url":"https://ids.usitc.gov/case/8276/investigation/8728","url":"https://api.ai-analytics.org/trade-case/8728"},"_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://ids.usitc.gov/","primary_source_dataset":"USITC Investigations Database System (IDS)","generated_at":"2026-06-26T22:44:02.940Z"}}